Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well ixabepilone works in treating patients with
metastatic, recurrent, or unresectable kidney cancer. Drugs used in chemotherapy, such as
ixabepilone, work in different ways to stop the growth of tumor cells, either by killing the
cells or by stopping them from dividing